Back
Cue Biopharma Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16
CUE
Cue Biopharma
Last Price:
1.04
Seasonality Move:
13.31%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Cue Biopharma Price Quote
$1.04
-0.05 (-4.59%)
(Updated: November 21, 2024 at 5:55 PM ET)
Cue Biopharma Key Stats
Sell
16
Cue Biopharma (CUE)
is a Sell
Day range:
$1.05 - $1.17
52-week range:
$0.45 - $3.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.71
P/B ratio:
2.75%
Volume:
409.1K
Avg. volume:
825.4K
1-year change:
-55.33%
Market cap:
$69.7M
Revenue:
$5.5M
EPS:
$-0.91
How Much Does Cue Biopharma Make?
-
How Much Are Cue Biopharma's Sales Annually?
CUE Revenues are $5.5M -
How Much Profit Does Cue Biopharma's Make A Year?
CUE net income is -$50.7M
Is Cue Biopharma Growing As A Company?
-
What Is Cue Biopharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.59% -
What Is Cue Biopharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Cue Biopharma Stock Price Performance
-
Did Cue Biopharma Stock Go Up Last Month?
Cue Biopharma share price went down by -9.92% last month -
Did CUE's Share Price Rise Over The Last Year?
CUE share price fell by -55.33% over the past 1 year
What Is Cue Biopharma 52-Week High & Low?
-
What Is Cue Biopharma’s 52-Week High Share Price?
Cue Biopharma has traded as high as $3.25 over the past 52 weeks -
What Is Cue Biopharma’s 52-Week Low Share Price?
Cue Biopharma has traded as low as $0.45 over the past 52 weeks
Cue Biopharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Cue Biopharma?
-
How Much Debt Does Cue Biopharma Have?
Total long term debt quarterly is $5.3M -
How Much Cash Does Cue Biopharma Have?
Cash and short term investments quarterly total is $32.4M -
What Is Cue Biopharma’s Book Value Per Share?
Book value per share is 0.42
Is Cue Biopharma Cash Flow Positive?
-
What Is CUE Cash Flow From Operations?
Cash flow from operations (TTM) is -$38.3M -
What Is Cue Biopharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $16M -
What Is Cue Biopharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $33K
Cue Biopharma Return On Invested Capital
-
Is Management Doing A Good Job?
CUE return on invested capital is -115.69% -
What Is Cue Biopharma Return On Assets?
ROA measures how assets are converting to revenues and is -82.16% -
What Is CUE Return On Equity?
ROE is a measure of profitability and is -142.28%
Cue Biopharma Earnings Date & Stock Price
-
What Is Cue Biopharma's Stock Price Today?
A single share of CUE can be purchased today for 1.09 -
What Is Cue Biopharma’s Stock Symbol?
Cue Biopharma trades on the nasdaq under the ticker symbol: CUE -
When Is Cue Biopharma’s Next Earnings Date?
The next quarterly earnings date for Cue Biopharma is scheduled on April 8, 2025 -
When Is CUE's next ex-dividend date?
Cue Biopharma's next ex-dividend date is May 26, 2020 -
How To Buy Cue Biopharma Stock?
You can buy Cue Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Cue Biopharma Competitors
-
Who Are Cue Biopharma's Competitors?
Below is a list of companies who compete with Cue Biopharma or are related in some way:
Cue Biopharma Dividend Yield
-
What Is CUE Dividend Yield?
Cue Biopharma’s dividend yield currently is 0% -
What Is Cue Biopharma’s Payout Ratio?
Cue Biopharma’s payout ratio is 0% -
When Did Cue Biopharma Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Cue Biopharma’s Dividend Per Share?
Cue Biopharma pays a dividend of $0.00 per share
Cue Biopharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 10.03% |
| Revenue: | 58.86% | 119.55% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 3.60 |
| Upside from Last Price: | 230.28% |